TrialAdvances in therapy2020

Pharmacokinetics and Safety of Single-Dose Esaxerenone in Japanese Subjects with Mild to Moderate Hepatic Impairment.

Akifumi Kurata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.